Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fay

Showing results (271-280 of 395) with videos related to

Pageof 40
Sort By:
The Journal of Biological Chemistry|June 6, 1997
Inhibition of HIV-1 replication using a mutated tRNALys-3 primerY Lu, V Planelles, X Li, et al.
Bulletin of the World Health Organization|September 2, 2024
Home visits versus fixed-site care by community health workers and child survival: a cluster-randomized trial, MaliJenny Liu, Emily Treleaven, Caroline Whidden, et al.
BMJ Open|August 29, 2019
Proactive community case management and child survival: protocol for a cluster randomised controlled trialCaroline Whidden, Emily Treleaven, Jenny Liu, et al.
Future Oncology (London, England)|August 11, 2022
Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancerNeeraj Agarwal, Arun Azad, Neal D Shore, et al.
Environmental Management|September 2, 2018
Leveraging Big Data Towards Functionally-Based, Catchment Scale Restoration PrioritizationJohn P Lovette, Jonathan M Duncan, Lindsey S Smart, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2009
Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assayKazutoyo Miura, Hong Zhou, Ababacar Diouf, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2020
Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common CharacteristicsFei Li Kuang, Bryan F Curtin, Hawwa Alao, et al.
European Urology|June 26, 2012
BRAF mutations in metanephric adenoma of the kidneyToni K Choueiri, John Cheville, Emanuele Palescandolo, et al.
Future Oncology (London, England)|January 26, 2022
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study designNeeraj Agarwal, Arun Azad, Neal D Shore, et al.
European Urology Focus|July 21, 2017
Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaGuillermo de Velasco, Kathryn P Gray, Lana Hamieh, et al.
Pageof 40

Showing results (271-280 of 395) with videos related to

Sort By:
Pageof 40
The Journal of Biological Chemistry|June 6, 1997
Inhibition of HIV-1 replication using a mutated tRNALys-3 primerY Lu, V Planelles, X Li, et al.
Bulletin of the World Health Organization|September 2, 2024
Home visits versus fixed-site care by community health workers and child survival: a cluster-randomized trial, MaliJenny Liu, Emily Treleaven, Caroline Whidden, et al.
BMJ Open|August 29, 2019
Proactive community case management and child survival: protocol for a cluster randomised controlled trialCaroline Whidden, Emily Treleaven, Jenny Liu, et al.
Future Oncology (London, England)|August 11, 2022
Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancerNeeraj Agarwal, Arun Azad, Neal D Shore, et al.
Environmental Management|September 2, 2018
Leveraging Big Data Towards Functionally-Based, Catchment Scale Restoration PrioritizationJohn P Lovette, Jonathan M Duncan, Lindsey S Smart, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2009
Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assayKazutoyo Miura, Hong Zhou, Ababacar Diouf, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 29, 2020
Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common CharacteristicsFei Li Kuang, Bryan F Curtin, Hawwa Alao, et al.
European Urology|June 26, 2012
BRAF mutations in metanephric adenoma of the kidneyToni K Choueiri, John Cheville, Emanuele Palescandolo, et al.
Future Oncology (London, England)|January 26, 2022
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study designNeeraj Agarwal, Arun Azad, Neal D Shore, et al.
European Urology Focus|July 21, 2017
Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaGuillermo de Velasco, Kathryn P Gray, Lana Hamieh, et al.
Pageof 40